Der Wirkstoff Apilimod könnte eine neue Hoffnung auf Behandlung von Hepatitis-E-Infektionen sein.

Sehr intressantes Interview unsere GfV-Präsidentin. (BS) www.pharmazeutische-zeitung.de/am-ende-zaeh...

Cool perspective on our latest paper using bemnifosbuvir against #HEV in GUT @bmj.com. gut.bmj.com/content/earl... #HepatitisE #Research #Virology #RUB #HepEHub

ℹ️ Apilimod blocks hepatitis E virus infection ℹ️ New study: PIKfyve inhibitor apilimod effectively blocks HEV infection. 🛋️ Read more: egastroenterology.bmj.com/content/4/1/... #HEV #HepatitisE #Research #Virology #RUB #HepEHub

Congratulations Tina 🎉 Thrilled to announce that Tina Sliwinski from @mmv-rub.bsky.social won the prestigous GBM Master Prize for her outstanding master's thesis 🔬 We're so proud of your achievement and look forward to your upcoming #PhD work on the spread of #HEV 🥼 @ruhr-uni-bochum.de

🔬 New insights into hepatitis E virus replication 🔬 Study reveals HEV replication occurs in proliferative cells within the intestinal crypt. Read more: www.science.org/doi/10.1126/... #HEV #HepatitisE #Research #Virology #RUB #HepEHub

🚨 Bemnifosbuvir shows promise against hepatitis E virus 🚨 New study: Nucleotide analogue bemnifosbuvir inhibits HEV replication in preclinical models. 💻: gut.bmj.com/content/earl... #HEV #HepatitisE #Research #Virology #RUB #HepEHub

🚨 Hoffnung im Kampf gegen Hepatitis E: Als Teil eines internationalen Teams hat die @mmv-rub.bsky.social an der Identifizierung eines Wirkstoffs mitgewirkt, der die Virusvermehrung gezielt stoppt – mit großem Potenzial für neue Therapien. 🎙️Radio Interview: bit.ly/4cx2Ckl 📰 Read more: bit.ly/47NAyqg

What a great meeting in Velbert last week 🔬 Under the title Advances in #HepatitisE Virus Infection Research, over 50 participants shared ideas and insights on clinical aspects, antiviral strategies, viral entry and replication 🧪 This is an amazing community, thanks to all of you 👇 #teamscience

Thanks to the Power of Didactics project at the University of Łódź, a member of the #UNIC, I had the opportunity to complete a short study visit at #MMV and #TRACIR at #RUB (Ruhr University Bochum). It was three days of learning and experiencing new scientific perspectives.

Welcome to the HepE-Hub Bochum! We're thrilled to connect the #virology & #infection research @mmv-rub.bsky.social & @compvirol.bsky.social here at @ruhr-uni-bochum.de with its 5 uni clinics to boost #HepatitisE research & patient care. Join us in our mission! #teamscience hepe-hub-bochum.de/en/

Exciting news! 🎉 We’re proud to be part of the new HepE-Hub Bochum initiative! Together with the uni clinics of @ruhr-uni-bochum.de and @mmv-rub.bsky.social, we’re committed to improve #HepatitisE virus #research and #healthcare Check it out 🔎 #virology #infectionresearch #TRACiR

@andregoemer.bsky.social diving into emerging Hepeviruses at the Applied Hygiene, Microbiology & Virology Conference.

Congrats @MaraKloehn great talk and a price 😁 at the FoRUM Tagung 2025 @ruhr-uni-bochum.de.

Ein Forschungsteam hat einen bislang unbekannten zellulären Mechanismus identifiziert, der für die Vermehrung von Coronaviren entscheidend ist.

Kudos @naturfuchs.bsky.social – cool talk #HCVFlavi2025 on rat liver cells as a model to study reverse zoonosis.

Our editorial “Rat Hepatitis E Virus: An Emerging Challenge in Human Hepatitis” is now out in the Journal of Hepatology! 👏 Thanks to Katja Dinkelborg (Medical School Hannover) and Sébastien Lhomme (CHU Toulouse) for the great teamwork and congrats to Lo et al. for their excellent original study!

Happy to share our latest work in NPJ viruses @natureportfolio.nature.com - JNK kinase regulates phosphorylation of HCoV-229E nucleocapsid protein. rdcu.be/eG4wf Kudos to all authors👏